Evaluation of cognitive behavioral therapy/motivational enhancement therapy (CBT/MET) in a treatment trial of comorbid MDD/AUD adolescents
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Objective Behavioral therapies developed specifically for co-occurring disorders remain sparse, and such therapies for comorbid adolescents are particularly rare. This was an evaluation of the long-term (2-year) efficacy of an acute phase trial of manualized cognitive behavioral therapy/motivation enhancement therapy (CBT/MET) versus naturalistic treatment among adolescents who had signed consent for a treatment study involving the SSRI antidepressant medication fluoxetine and CBT/MET therapy for comorbid major depressive disorder (MDD) and an alcohol use disorder (AUD). We hypothesized that improvements in depressive symptoms and alcohol-related symptoms noted among the subjects who had received CBT/MET would exceed that of those in the naturalistic comparison group that had not received CBT/MET therapy. Methods We evaluated levels of depressive symptoms and alcohol-related symptoms at a two-year follow-up evaluation among comorbid MDD/AUD adolescents who had received an acute phase trial of manual-based CBT/MET (in addition to the SSRI medication fluoxetine or placebo) compared to those who had received naturalistic care. Results In repeated measures ANOVA, a significant time by enrollment status difference was noted for both depressive symptoms and alcohol-related symptoms across the two-year time period of this study, with those receiving CBT/MET demonstrating superior outcomes compared to those who had not received protocol CBT/MET therapy. No significant difference was noted between those receiving fluoxetine versus those receiving placebo on any outcome at any time point. Conclusions These findings suggest long-term efficacy for an acute phase trial of manualized CBT/MET for treating comorbid MDD/AUD adolescents. Large multi-site studies are warranted to further clarify the efficacy of CBT/MET therapy among various adolescent and young adult comorbid populations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Beck, A. T., Steer, R. A., & Brown, G. (2011) · PsycTESTS Dataset · doi:10.1037/t00742-000 · Cited by 7,535
Mesa Grande: a methodological analysis of clinical trials of treatments for alcohol use disorders
Miller, W. R., & Wilbourne, P. L. (2002) · Addiction · doi:10.1046/j.1360-0443.2002.00019.x · Cited by 805 · cited 1×
“…therapy (MET), including the MET used in this study, is a brief intervention used to enhance an individual's engagement in therapy and motivation to make changes regarding substance use and high-risk behaviors (Miller, Zweben, DiClemente, & Rychtarik, 1992; Miller & Wibourne, 2002; Carroll, 2004).”
MethodBrent, D. A. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830210125017 · Cited by 753
Meta-analysis of Randomized Control Trials Addressing Brief Interventions in Heavy Alcohol Drinkers
Wilk, A. I., Jensen, N. M., & Havighurst, T. C. (1997) · Journal of General Internal Medicine · doi:10.1007/s11606-006-5063-z · Cited by 577
Efficacy of relapse prevention: A meta-analytic review.
Irvin, J. E., Bowers, C. A., Dunn, M. E., & Wang, M. C. (1999) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.67.4.563 · Cited by 424
Relapse prevention as a psychosocial treatment: A review of controlled clinical trials.
Carroll, K. M. (1996) · Experimental and Clinical Psychopharmacology · doi:10.1037/1064-1297.4.1.46 · Cited by 285
Double-blind fluoxetine trial in comorbid MDD-CUD youth and young adults.
Cornelius, J. R., Bukstein, O. G., Douaihy, A. B., Clark, D. B., Chung, T. A., Daley, D. C., Wood, D. S., & Brown, S. J. (2010) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2010.05.010 · Cited by 105 · cited 2×
“…such as clinical predictors, neuroimaging-related predictors, and genetic predictors of treatment response among comorbid populations (Cornelius et al., 1997; Cornelius, Bukstein, Salloum, & Clark, 2005; Cornelius & Clark, 2007; Cornelius, Aizenstein, & Hariri, 2010; Cornelius et al., 2010).”
BackgroundSelf-citation
Cited by
Antidepressants for the treatment of people with co-occurring depression and alcohol dependence
Agabio, R., Trogu, E., & Pani, P. P. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008581.pub2 · Cited by 131
Treating Mental Health and Substance Use Disorders in Adolescents: What Is on the Menu?
Brewer, S., Godley, M. D., & Hulvershorn, L. A. (2017) · Current Psychiatry Reports · doi:10.1007/s11920-017-0755-0 · Cited by 79
Pan, S., Jiang, H., Du, J., Chen, H., Li, Z., Ling, W., & Zhao, M. (2015) · PLOS ONE · doi:10.1371/journal.pone.0127598 · Cited by 49
“CBT alone or combined with pharmacological treatments has been used for substance use disorders (SUDs) [13,14], as well as for other mental health comobidities [15,16,17,18,19].”
Rohde, P., Waldron, H. B., Turner, C. W., Brody, J., & Jorgensen, J. (2014) · Journal of Consulting and Clinical Psychology · doi:10.1037/a0035808 · Cited by 47
“Cognitive behavioral therapy (CBT) has improved long-term depressive and alcohol outcomes relative to usual care (Cornelius et al., 2011), and CBT plus fluoxetine has been shown to reduce depressive symptoms (but not substance use) relative to CBT plus placebo (Riggs et al., 2007) in youth with…”
BackgroundGodley, S. H., Smith, J. E., Passetti, L. L., & Subramaniam, G. (2014) · Substance Abuse · doi:10.1080/08897077.2014.936993 · Cited by 42
Metadata
- Authors
- Cornelius, J. R., Douaihy, A., Bukstein, O. G., Daley, D. C., Wood, S. D., Kelly, T. M., & Salloum, I. M.
- Venue
- Addictive Behaviors
- Publisher
- Elsevier BV
- Published
- 2011-08
- Volume
- 36
- Issue
- 8
- Pages
- 843-848
- ISSN
- 0306-4603 (ISSN-L)
- OpenAlex
- W1984071623
- Cited by
- 73
- References
- 7
- FWCI
- 5.19
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.